erlocip 150 tablet

Therapeutic Class: ANTI NEOPLASTICS
Action Class: Tyrosine kinase inhibitors
Chemical Class: Quinazoline Derivative
Habit Forming: No

USES
Non-small cell lung cancer
Pancreatic cancer

SIDE EFFECTS
Abdominal pain
Bone pain
Breathlessness
Constipation
Cough
Diarrhea
Fatigue
Fever
Infection
Muscle pain
Nausea
Rash
Stomatitis (Inflammation of the mouth)
Vomiting
Weight loss

SUBSTITUTES
Zyceva 150mg Tablet
Erleva 150mg Tablet
Erlotirel 150mg Tablet
Etbmed 150mg Tablet
Erlotaz 150 Tablet
